Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex-Reference-Cited by-同舟云学术

Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex

Published:2020-12 Issue: Volume:180 Page:108297
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Theilmann Wiebke,Gericke Birthe,Schidlitzki Alina,Muneeb Anjum Syed Muhammad,Borsdorf Saskia,Harries Timon,Roberds Steven L.,Aguiar Dean J.,Brunner Daniela,Leiser Steven C.,Song Dekun,Fabbro Doriano,Hillmann Petra,Wymann Matthias P.,Löscher Wolfgang

Funder

Epilepsy Foundation

Innosuisse

Novartis Foundation for medical-biological Research

Swiss National Science Foundation

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference70 articles.

1. TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice;Abs;Ann. Neurol.,2013

2. Automated quantification of EEG spikes and spike clusters as a new read out in Theiler's virus mouse model of encephalitis-induced epilepsy;Anjum;Epilepsy Behav.,2018